LeMaitre Vascular, Inc. (LMAT)
Upgrades & Downgrades
Latest LMAT news
How Much Upside is Left in LeMaitre (LMAT)? Wall Street Analysts Think 25.24%
10 November 2023
The consensus price target hints at a 25.2% upside potential for LeMaitre (LMAT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate...
LeMaitre to Participate at Upcoming Investor Conferences in November
3 November 2023
BURLINGTON, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in November.
LeMaitre Vascular, Inc. (LMAT) Q3 2023 Earnings Call Transcript
1 November 2023
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q3 2023 Earnings Conference Call November 1, 2023 5:00 PM ET Company Participants Joseph Pellegrino - Chief Financial Officer George LeMaitre - Chief Executive O...
PETQ or LMAT: Which Is the Better Value Stock Right Now?
23 October 2023
Investors looking for stocks in the Medical - Products sector might want to consider either PetIQ (PETQ) or LeMaitre Vascular (LMAT). But which of these two stocks is more attractive to value investor...
LeMaitre to Present at the 2023 Cantor Global Healthcare Conference
21 September 2023
BURLINGTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at 2023 Cantor Global Healthcare Conference on T...
Looking for Dividend Growth? Buy This Little-Known Healthcare Stock
1 September 2023
LeMaitre Vascular's sales and profits surged in the second quarter. The company's dividend is supported by earnings.
2 Healthcare Stocks That Could Help Make You a Fortune
26 August 2023
Cigna and LeMaitre each appear to have decent growth prospects. Both companies pay well-covered dividends to shareholders.
LeMaitre: Record Quarter, ASPs And Volumes Ratcheting Higher Equals Qualified Growth Outlook
24 August 2023
LeMaitre Vascular's stock offers attractive long-term investment prospects, with recent consolidations offering an entry point for investors. The company reported record quarterly sales in Q2 and is e...
Atrion Corp (ATRI): A Medical Device Stock with Good Outperformance Potential
8 August 2023
Atrion Corp ( ATRI , Financial), a leading player in the Medical Devices & Instruments industry, is currently trading at $557 per share. The company has a market capitalization of $980.596 million and...